Nantcell is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Trademark Applications
Trademark applications show the products and services that Nantcell is developing and marketing.
Nantcell doesn't have any recent trademark applications, indicating Nantcell is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
IMMUNITYBIO CARE Providing an Internet portal serving as a hub for information about a customer's medical and health services, including information about medical providers, benefit investigation, prior authorization processing, patient education, and financial and co-pay assistance; Providing temporary use of online non-downloadable software for allowing patients and customers of medical or health services to access benefit investigation, prior authorization processing, patient education, and financial and co-pay assistance; Providing temporary use of online non-downloadable software for allowing a single location to provide patient services to patients and customers of medical or health services; Providing temporary use of online non-downloadable software for medical and healthcare patients and customers that enables users to access and monitor health and medical information and reports; Providing temporary use of online non-downloadable software for medical and health hub services, namely, patient support services, co-pay assistance, billing and account receivables, shipping and reporting, patient data aggregation and analysis, placing and tracking prescription medication orders, tracking and analyzing patient clinical care outcomes, receiving, processing, transmitting, and displaying data, controlling and managing patient health information, and medical and healthcare analytics; Providing temporary use of online non-downloadable software for a centralized patient portal to permit the secure access of patient information and to access, maintain, manage and distribute patient medical information and other healthcare information, and to facilitate communications, connectivity and workflow with health care providers, healthcare organizations and patients; Providing temporary use of online non-downloadable software for managing medical information
11/14/2023
ADENOCAP Pharmaceutical preparations for the treatment of COVID-19 and human adenovirus infections for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of COVID-19 and human adenovirus infections; diagnostic kits for COVID-19 and human adenovirus infections for medical or clinical use; vaccines for COVID-19 and human adenovirus infections
07/10/2020
IMMUNITYBIO Pharmaceutical preparations for the treatment of cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for immunotherapy treatment; diagnostic kits consisting primarily of cells for medical or clinical use
06/12/2019
See all trademarks and details in the Full Report.
Market Share of Nantcell's Largest Competitors
A competitive analysis shows these companies are in the same general field as Nantcell, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Nantcell.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Nantcell and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.